News
We provide the latest news from the world of economics and finance
(RTTNews) - Shares of Day One Biopharmaceuticals, Inc. (DAWN) are surging about 65 percent on Friday morning trading after Servier, an independent international pharmaceutical group, agreed to acquire the company for $21.50 per share in cash.
The company's shares are currently trading at $21.15 on the Nasdaq, up 65.49 percent. The stock opened at $21.12 and has climbed as high as $21.19 so far in today's session. Over the past year, it has traded in a range of $5.64 to $21.19.
Day One expects the acquisition to represent a unique opportunity to extend the reach of its science and its lead program in pediatric low-grade glioma. The deal is estimated to be completed in the second quarter of 2026.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
© 2026 Lime Trading (CY) Ltd
Lime Trading (CY) Ltd is authorised and regulated by the Cyprus Securities and Exchange Commission in accordance with license No.281/15 issued on 25/09/2015. The "Just2Trade" trademark is owned by LimeTrading (CY) Ltd.
Registration Number: HE 341520
Address: Lime Trading (CY) Ltd
Magnum Business Center, Office 4B, Spyrou Kyprianou Avenue 78
Limassol 3076, Cyprus
Disclaimer:
All promotions, materials and information of this website may have applied conditions. Please contact the Company for further details
Trading on financial markets carries risks. The value of the investments can both increase and decrease and the investors may lose all their investment capital. In case of a leveraged product, the loss may be more than the initial capital invested. Detailed information on risks associated with trading on financial markets can be found in General Terms and Conditions for the Provision of Investment Services.
E-mail: 24_support@j2t.com
